- B2B
- Growth StageExpanding market presence
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
PostEra careers
PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with [Amgen](endpts.com/amgen-lines-up-new-ai-biotech-partner-in-postera), [Pfizer](endpts.com/a-new-ai-startup-has-emerged-and-pfizer-likes-what-it-sees) and the [NIH](endpts.com/nih-grants-over-500m-to-create-antivirals-for-future-pandemics). PostEra also launched and led the world's largest open-science drug discovery effort; [COVID Moonshot](postera.ai/moonshot).
General Interest
Remote
yesterday
Aaron Morris
Valuation
$0
Funded over
2 rounds
Latest round

